| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 149, 1055-1062, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
WM van Weerden, CM de Ridder, CL Verdaasdonk, JC Romijn, TH van der Kwast, FH Schroder and GJ van Steenbrugge
Department of Urology, Erasmus University, Rotterdam, The Netherlands.
Seven human prostate tumor models were established by transplanting tumor fragments in NMRI athymic nude mice. Once established, the tumors were serially transplantable in both NMRI and BALB/c nude mice. The xenografts originated from primary prostatic carcinomas (prostatectomy specimens), transurethral resection material, and metastatic lesions (pelvic lymph nodes and scrotal skin). Histological examination revealed that, in the course of several mouse passages (8 to 23), tumors retained their resemblance to the original patient material. The PC-295, PC-310, PC-329, and PC-346 tumors are dependent on androgens for their growth. The PC-324, PC-339, and PC-374 tumors are androgen independent, although growth of PC-374 tumors still seemed androgen sensitive. All tumors are diploid, except for the PC-374, which is tetraploid. The diploid PC-295 tumor has an additional small population of tetraploid cells. All xenografts displayed a heterogeneous expression pattern of the androgen receptor except for the PC-324 and PC-339 tumors in which the androgen receptor could not be detected. Prostatic acid phosphatase and prostate-specific antigen were retained during serial transplantation in all tumors but the PC-324 and PC-339. This panel of permanent human prostate tumor models comprises tumors representing both the androgen-dependent and -independent stages of human prostate cancer with various degrees of differentiation and, therefore, is of great value for the study of many aspects of growth and progression of human prostate cancer.
This article has been cited by other articles:
 |
|
 |
|
  K. G. Hermans, A. A. Bressers, H. A. van der Korput, N. F. Dits, G. Jenster, and J. Trapman Two Unique Novel Prostate-Specific and Androgen-Regulated Fusion Partners of ETV4 in Prostate Cancer Cancer Res., May 1, 2008; 68(9): 3094 - 3098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. de Visser, W. M. van Weerden, C. M.A. de Ridder, S. Reneman, M. Melis, E. P. Krenning, and M. de Jong Androgen-Dependent Expression of the Gastrin-Releasing Peptide Receptor in Human Prostate Tumor Xenografts J. Nucl. Med., January 1, 2007; 48(1): 88 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. G. Hermans, R. van Marion, H. van Dekken, G. Jenster, W. M. van Weerden, and J. Trapman TMPRSS2:ERG Fusion by Translocation or Interstitial Deletion Is Highly Relevant in Androgen-Dependent Prostate Cancer, But Is Bypassed in Late-Stage Androgen Receptor-Negative Prostate Cancer. Cancer Res., November 15, 2006; 66(22): 10658 - 10663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. V. Heemers, G. Verhoeven, and J. V. Swinnen Androgen Activation of the Sterol Regulatory Element-Binding Protein Pathway: Current Insights Mol. Endocrinol., October 1, 2006; 20(10): 2265 - 2277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.-J. C. M. van den Bemd, J. Krijgsveld, T. M. Luider, A. L. van Rijswijk, J. A. A. Demmers, and G. Jenster Mass Spectrometric Identification of Human Prostate Cancer-derived Proteins in Serum of Xenograft-bearing Mice Mol. Cell. Proteomics, October 1, 2006; 5(10): 1830 - 1839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J.M. Hendriksen, N. F.J. Dits, K. Kokame, A. Veldhoven, W. M. van Weerden, C. H. Bangma, J. Trapman, and G. Jenster Evolution of the Androgen Receptor Pathway during Progression of Prostate Cancer. Cancer Res., May 15, 2006; 66(10): 5012 - 5020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Limpens, F. H. Schroder, C. M. A. de Ridder, C. A. Bolder, M. F. Wildhagen, U. C. Obermuller-Jevic, K. Kramer, and W. M. van Weerden Combined Lycopene and Vitamin E Treatment Suppresses the Growth of PC-346C Human Prostate Cancer Cells in Nude Mice J. Nutr., May 1, 2006; 136(5): 1287 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jung, R.-S. Kim, H.-J. Zhang, S.-J. Lee, and M.-H. Jeng HOXB13 Induces Growth Suppression of Prostate Cancer Cells as a Repressor of Hormone-Activated Androgen Receptor Signaling Cancer Res., December 15, 2004; 64(24): 9185 - 9192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. T G Chang, M. Jhamai, W. M van Weerden, G. Jenster, and A. O Brinkmann The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer Endocr. Relat. Cancer, December 1, 2004; 11(4): 815 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Gray, W. J. Huss, J. M. Yau, L. E. Durham, E. S. Werdin, W. K. Funkhouser Jr., and G. J. Smith Short-Term Human Prostate Primary Xenografts: An in Vivo Model of Human Prostate Cancer Vasculature and Angiogenesis Cancer Res., March 1, 2004; 64(5): 1712 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D. True, K. Buhler, J. Quinn, E. Williams, P. S. Nelson, N. Clegg, J. A. Macoska, T. Norwood, A. Liu, W. Ellis, et al. A Neuroendocrine/Small Cell Prostate Carcinoma Xenograft--LuCaP 49 Am. J. Pathol., August 1, 2002; 161(2): 705 - 715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Heemers, B. Maes, F. Foufelle, W. Heyns, G. Verhoeven, and J. V. Swinnen Androgens Stimulate Lipogenic Gene Expression in Prostate Cancer Cells by Activation of the Sterol Regulatory Element-Binding Protein Cleavage Activating Protein/Sterol Regulatory Element-Binding Protein Pathway Mol. Endocrinol., October 1, 2001; 15(10): 1817 - 1828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Presnell, E. S. Werdin, S. Maygarden, J. L. Mohler, and G. J. Smith Establishment of Short-Term Primary Human Prostate Xenografts for the Study of Prostate Biology and Cancer Am. J. Pathol., September 1, 2001; 159(3): 855 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. de Pinieux, M.-E. Legrier, F. Poirson-Bichat, Y. Courty, R. Bras-Goncalves, A.-M. Dutrillaux, F. Nemati, S. Oudard, R. Lidereau, P. Broqua, et al. Clinical and Experimental Progression of a New Model of Human Prostate Cancer and Therapeutic Approach Am. J. Pathol., August 1, 2001; 159(2): 753 - 764. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. R. Mallery, P. Pei, J. Kang, G. Zhu, G. M. Ness, and S. P. Schwendeman Sustained angiogenesis enables in vivo transplantation of mucocutaneous derived AIDS-related Kaposi's sarcoma cells in murine hosts Carcinogenesis, September 1, 2000; 21(9): 1647 - 1653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Holleran, C. J. Miller, and L. A. Culp Tracking Micrometastasis to Multiple Organs with lacZ-tagged CWR22R Prostate Carcinoma Cells J. Histochem. Cytochem., May 1, 2000; 48(5): 643 - 652. [Abstract] [Full Text]
|
|
|
|
|
|
J. Jongsma, M. H. Oomen, M. A. Noordzij, W. M. Van Weerden, G. J. M. Martens, T. H. van der Kwast, F. H. Schröder, and G. J. van Steenbrugge Androgen Deprivation of the Prohormone Convertase-310 Human Prostate Cancer Model System Induces Neuroendocrine Differentiation Cancer Res., February 1, 2000; 60(3): 741 - 748. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. S. Hubert, I. Vivanco, E. Chen, S. Rastegar, K. Leong, S. C. Mitchell, R. Madraswala, Y. Zhou, J. Kuo, A. B. Raitano, et al. STEAP: A prostate-specific cell-surface antigen highly expressed in human prostate tumors PNAS, December 7, 1999; 96(25): 14523 - 14528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Jongsma, M. H. Oomen, M. A. Noordzij, W. M. Van Weerden, G. J. M. Martens, T. H. van der Kwast, F. H. Schroder, and G. J. van Steenbrugge Kinetics of Neuroendocrine Differentiation in an Androgen-Dependent Human Prostate Xenograft Model Am. J. Pathol., February 1, 1999; 154(2): 543 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Verhaegh, A. van Bokhoven, F. Smit, J. A. Schalken, and M. J. G. Bussemakers Isolation and Characterization of the Promoter of the Human Prostate Cancer-specific DD3 Gene J. Biol. Chem., November 22, 2000; 275(48): 37496 - 37503. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
